ロード中...
Pemetrexed in maintenance treatment of advanced non-squamous non-small-cell lung cancer
Pemetrexed, a multitargeting antifolate cytotoxic drug, plays a leading role in front-line chemotherapy for patients with advanced non-squamous non-small-cell lung cancer (NSCLC). Following its approval as second-line monotherapy for locally advanced or metastatic non-squamous NSCLC, pemetrexed has...
保存先:
| 出版年: | Lung Cancer (Auckl) |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Dove Medical Press
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5217518/ https://ncbi.nlm.nih.gov/pubmed/28210147 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/LCTT.S73268 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|